Iastrebner, Marcelo <br/><br/>
Decitabine in myelodysplastic syndromes and chronic myelomonocytic leukemia: Argentinian/South Korean multi-institutional clinical experience.  [electronic resource] 

 -  Leukemia & lymphoma  Dec 2010 
 - 2250-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2010.524324  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Argentina<br/>Azacitidine--administration & dosage<br/>Decitabine<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Injections, Intravenous<br/>Leukemia, Myelomonocytic, Chronic--drug therapy<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--drug therapy<br/>Remission Induction<br/>Republic of Korea<br/>Survival Analysis<br/>Treatment Outcome<br/>Young Adult